-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Talis Biomedical Corp quarterly/annual Earnings Per Share, Diluted history and change rate from Q3 2021 to Q2 2024.
- Talis Biomedical Corp Earnings Per Share, Diluted for the quarter ending 30 Jun 2024 was -4.86 USD/shares, a 41.2% increase year-over-year.
- Talis Biomedical Corp Earnings Per Share, Diluted for the twelve months ending 30 Jun 2024 was -28 USD/shares, a 56.6% increase year-over-year.
- Talis Biomedical Corp annual Earnings Per Share, Diluted for 2023 was -34.1 USD/shares, a 45.6% increase from 2022.
- Talis Biomedical Corp annual Earnings Per Share, Diluted for 2022 was -62.8 USD/shares, a 640% decline from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)